New Key Statistics Module, Z-Score and F-Score
TSXV:RX Key Ratios
Market Cap C$ M | 127.46 |
Enterprise Value C$ M | 111.18 |
P/E(ttm) | 18.36 |
PE Ratio without NRI | 18.36 |
Forward PE Ratio | 19.11 |
Price/Book | 3.60 |
Price/Sales | 3.88 |
Price/Free Cash Flow | 57.29 |
Price/Owner Earnings | 47.41 |
Payout Ratio % | 0.28 |
Revenue (TTM) C$ M | 33.00 |
EPS (TTM) C$ | 0.60 |
Beneish M-Score | 0.8 |
10-y EBITDA Growth Rate % | 12.10 |
5-y EBITDA Growth Rate % | 9.40 |
y-y EBITDA Growth Rate % | 33.00 |
EV-to-EBIT | 11.66 |
EV-to-EBITDA | 11.11 |
PEG | 1.95 |
Shares Outstanding M | 11.59 |
Net Margin (%) | 21.14 |
Operating Margin % | 24.61 |
Pre-tax Margin (%) | 28.01 |
Quick Ratio | 4.90 |
Current Ratio | 6.13 |
ROA % (ttm) | 17.53 |
ROE % (ttm) | 20.75 |
ROIC % (ttm) | 55.29 |
Dividend Yield % | 1.59 |
Altman Z-Score | 15.88 |
TSXV:RX Number of Guru Trades
TSXV:RX Volume of Guru Trades
Gurus Latest Trades with TSXV:RX
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
TSXV:RX is held by these investors
You need a Premium membership or above to view this section.
Take a 7-Day Free Trial
No Available Data
Biosyent Inc Insider Transactions
No Available Data